Relation of Non-invasively Measured Parameters to Clinical Outcomes in CHF Patients - Trial NCT04548024
Access comprehensive clinical trial information for NCT04548024 through Pure Global AI's free database. This phase not specified trial is sponsored by Biobeat Technologies Ltd. and is currently Completed. The study focuses on Congestive Heart Failure. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Biobeat Technologies Ltd.
Timeline & Enrollment
N/A
Sep 10, 2020
Dec 10, 2021
Primary Outcome
To assess whether the changes in vital signs during IV diuretic administration correlate with short-term clinical change.
Summary
Our aim is to assess whether changes in CO, CI and SVR as measured using the Biobeat
 wearable, wireless, non-invasive device during IV diuretic administration in an outpatient
 setting among CHF patients correlate with short-term clinical change measured using symptoms
 questionnaires, change in weight and urine output. We will also assess the correlation
 between baseline values of those parameters and long-term clinical outcomes, measured by HF
 hospitalizations and the change in disease perception and quality of life reported in
 questionnaires.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04548024
Device Trial